Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
#Blood Stream Infection Testing Market Size And Revenue Forecast Through 2030
The market for bloodstream infection testing experienced substantial expansion lately, advancing from an $8.49 billion valuation in 2025 to an anticipated $9.5 billion by 2026, reflecting a compound annual growth rate of 11.9%. This recorded growth trajectory was propelled by several key factors, including a heightened prevalence of bloodstream infections, escalating rates of hospital-acquired infections, the proliferation of clinical microbiology laboratories, the widespread adoption of automated diagnostic tools, and a heightened global consciousness regarding effective sepsis management strategies.
The market dedicated to detecting bloodstream infections is poised for significant expansion in the coming years, projected to reach a valuation of $14.71 billion by 2030, fueled by a compound annual growth rate of 11.6%. This projected surge is underpinned by several key drivers, including a heightened need for expedited diagnostic results, the increasing integration of molecular diagnostic techniques within healthcare facilities, the broadening scope of personalized approaches to infection management, augmented investments in sophisticated laboratory infrastructure, and the growing incorporation of artificial intelligence-driven diagnostic solutions. Furthermore, prevailing trends expected to shape this market during the forecast period involve a greater embrace of swift molecular diagnostic tests, a rise in the utilization of automated blood culture systems, enhanced integration of antimicrobial susceptibility testing, the proliferation of comprehensive pathogen detection panels, and a more pronounced emphasis on the early identification of sepsis.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20514&type=smp
#Blood Stream Infection Testing Market Growth Drivers And Industry Catalysts
A surge in the incidence of infectious illnesses is anticipated to be a primary driver for the expansion of the bloodstream infection testing market. These ailments, stemming from pathogenic agents like bacteria, viruses, fungi, or parasites, are becoming more common due to a confluence of elements including heightened international travel, urban development, shifts in climate, growing resistance to antibiotics, and deficiencies in immunization programs. Crucially, bloodstream infection diagnostics play a vital role in the management of infectious diseases by pinpointing the specific microbes responsible for sepsis and other grave infections, thereby facilitating prompt and appropriate therapeutic interventions. A pertinent example, as noted by the World Health Organization in October 2024, is the rise in tuberculosis diagnoses. This global health entity reported roughly 8.2 million new cases in 2023, an increase from approximately 7.5 million in 2022, establishing tuberculosis as the foremost infectious disease causing fatalities. Consequently, the escalating occurrence of infectious diseases is directly fueling the demand within the bloodstream infection testing sector.
Blood Stream Infection Testing Market Segment Analysis And Revenue Opportunities
The blood stream infection testing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents And Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services
#Blood Stream Infection Testing Market Trends Influencing Long-Term Demand
The primary entities within the bloodstream infection testing sector are prioritizing the integration of cutting-edge methodologies, including host-response diagnostics powered by machine learning, aiming for accelerated identification, enhanced clinical decision support, and ultimately, improved patient care. These host-response diagnostic systems scrutinize a patient’s immunological response through gene expression patterns found in blood, employing artificial intelligence algorithms to ascertain in real-time the presence, nature, and probable severity of an infection, thereby enabling medical professionals to reach swifter and more precise therapeutic choices. As an illustration, in January of 2025, Inflammatix Inc., a molecular diagnostics firm situated in the United States, secured approval from the U.S. Food and Drug Administration for TriVerity, a molecular blood assay driven by machine learning, intended to facilitate the swift assessment of individuals suspected of acute infections or sepsis; this test quantifies 29 immune-related messenger RNAs and generates AI-driven scores that reflect the probability of bacterial infection, viral infection, and the likelihood of severe illness, with outcomes anticipated within approximately half an hour. TriVerity contributes to clinical decision-making by mitigating diagnostic ambiguity, supporting prompt, targeted treatments, and aiding in the efficient allocation of hospital resources when employed in conjunction with conventional clinical assessments and laboratory data.
Blood Stream Infection Testing Market Leading Players Shaping Industry Direction
Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMÉRIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.
Access The Complete Blood Stream Infection Testing Market Report:
Blood Stream Infection Testing Market Geographic Landscape: Which Region Dominates Industry Growth?
North Americawas the largest region in the blood stream infection testing market in 2025. The regions covered in the blood stream infection testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
